Talk around weight in the United States has reached a fever pitch thanks to the popularity of injectable GLP-1 medications, ...

New CDC data reveals a concerning rise in severe obesity among U.S. adults, with women and middle-aged individuals most affected. The obesity epidemic continues to strain the healthcare system with ...

The percentage of U.S. adults with obesity did not significantly rise from 2013 to 2023, though a small uptick in the rate of obesity was seen for children and adolescents, according to data published ...

Severe obesity in childhood and adolescence more than triples the risk of MS, and obesity treatment does not seem to reverse ...

A group of 58 researchers is calling for a new, better way to measure obesity. The global team’s recommendations were published in The Lancet Diabetes & Endocrinology on Jan. 14. Body mass index ...

If you have obesity, losing even a little weight helps not only improve your overall health, but also prevent liver issues ...

From 2013-2014 to August 2021-August 2023, there were small increases in the percentage of children and adolescents with obesity, as well as in adults with severe obesity (but not obesity). There were ...

The main results of the SUMMIT trial, reported last year, showed that tirzepatide—a dual glucose-dependent insulinotropic ...

Jan. 27, 2025 — A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future ... Signposting Children to ...

In nine out of ten patients with type 2 diabetes, severe obesity, known as adiposity, leads to diabetes. Type 2 diabetes is ...

Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest ...